Metraipolis › archive › dc_ed727dec53e5

Refractory Hypophosphatemia Secondary to Tumor-Induced Osteomalacia: Diagnostic Challenges and Successful Management With Burosumab — Europe PMC PMID:40951211

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40951211
DOI
10.7759/cureus.90016
License (as archived)
solo-consultazione
Archived
2026-11-10T15:57:21.417Z
SHA-256 of the archived text
25c33a191709510cb9f5617142ca9e0b1721ea83df7807a0abb7c4bc601d6d95
Stable URL of this page
https://metraipolis.com/documento/dc_ed727dec53e5

How to cite

Refractory Hypophosphatemia Secondary to Tumor-Induced Osteomalacia: Diagnostic Challenges and Successful Management With Burosumab — Europe PMC PMID:40951211 — Europe PMC (en), https://europepmc.org/article/MED/40951211 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ed727dec53e5 (Metraipolis archive dc_ed727dec53e5, sha256 25c33a191709510cb9f5617142ca9e0b1721ea83df7807a0abb7c4bc601d6d95)
BibTeX
@misc{dced727dec53e5,
  title = {Refractory Hypophosphatemia Secondary to Tumor-Induced Osteomalacia: Diagnostic Challenges and Successful Management With Burosumab — Europe PMC PMID:40951211},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40951211},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ed727dec53e5; sha256 25c33a191709510cb9f5617142ca9e0b1721ea83df7807a0abb7c4bc601d6d95},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40951211. Agents can read the archived copy with the MCP tool read_document.